ZoaDx to Join CovarsaDx at ADLM 2025 to Advance Veterinary Diagnostics Research
ZoaDx, a full-service animal health clinical research organization (CRO) specializing in veterinary diagnostics, therapeutics, and vaccines, will showcase alongside its human health CRO counterpart, CovarsaDx, at Booth #4334 during the 2025 Association for Diagnostics & Laboratory Medicine Conference (ADLM) Annual Scientific Meeting & Clinical Lab Expo at McCormick Place Convention Center in Chicago July 27-31.
ZoaDx’s participation underscores the growing importance of cross-sector innovation in diagnostics—and the unique opportunity to engage with both human and veterinary CRO experts in one place. ZoaDx brings practical insights, a collaborative approach, and expert consultancy to meet the clinical study needs of customers of all sizes.
The ADLM Clinical Lab Expo is the premier gathering for global laboratory medicine, bringing together clinical lab professionals, exhibitors, and leaders in the laboratory medicine sector, including those in veterinary medicine. ADLM 2025 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo) is a program of the Association for Diagnostics & Laboratory Medicine and is held this year in partnership with the Canadian Society for Clinical Chemistry (CSCC). ZoaDx is paving the way for animal health companies to be part of that same innovation ecosystem, bringing veterinary diagnostics into the broader diagnostics conversation.
At Booth #4334, attendees can meet Marielle Lejcher, ZoaDx President and Senior Director of Regulatory Affairs & Quality at CovarsaDx, along with other members of the clinical and regulatory teams. Together, they’ll be available to discuss how ZoaDx supports animal health sponsors through every stage of bringing a product to market. ZoaDx will showcase its comprehensive solutions and services that highlight the company’s capabilities:
- Market strategy-proof of concept and opportunity assessment
- Method development and validation study design (pre-clinical and clinical) and services for veterinary diagnostics, therapeutics, and vaccines
- Application for study permits and licenses from regulatory authorities
- Monitoring
- Data management and statistical analysis
- Quality assurance and compliance
- Site selection based on species/disease prevalence and readiness
- Regulatory strategy for product development and lifecycle management
- Cross-functional integration with CovarsaDx for dual-market sponsors
Veterinary sponsors attending ADLM 2025 are encouraged to schedule time with the ZoaDx team by contacting Senior Director, Strategic Partnerships and Business Development Rich Masino at rich.masino@zoadx.com.
For more information on ZoaDx’s activities at ADLM, please visit the company website or visit the conference booth (#4434) to experience the full breadth of ZoaDx’s capabilities. For live updates during the event, follow ZoaDx on LinkedIn.
About ZoaDx
ZoaDx supports animal health and agricultural sustainability by offering precise, expert-driven clinical research and regulatory solutions. Through collaborative partnerships and innovative strategies, ZoaDx empowers clients to accelerate their path to market and achieve impactful results.
About CovarsaDx
CovarsaDx is a prominent Clinical Research Organization (CRO) specializing in the area of in-vitro diagnostics (IVDs) and medical devices. The company provides agile responses to patient population needs and fluctuations in regulatory requirements for rapid market pathways. Their team of regulatory, quality, and clinical experts have extensive industry experience and consist of regulatory strategists, quality experts, study managers, monitors, data managers, and statisticians who work together to deliver reliable clinical results, enabling clients to bring life-saving technologies to market efficiently.
